Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices.

Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint in Europe.

Read full article from Mass Device here. 

We are excited to hold our next professional education event this Friday and Saturday in San Diego! This symposium will be focused on the application of CLARIX and NEOX on the lower extremities and will include sessions on wound care, pain management, and surgical applications.

July is minority mental health awareness month!

#lgbtqia #mentalhealth #awareness @NAMICommunicate